Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01187771 · ClinicalTrials.gov registry record · Phase 2
Apnea, Bariatric Surgery Versus Continuous Positive Airway Pressure (CPAP) Trial
A Phase 2 study of Obesity and Obstructive Sleep Apnea, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 53
- Enrollment target
- 2
- Study locations
NCT01187771: Completed Phase 2 study of Obesity and Obstructive Sleep Apnea, sponsored by University of Pittsburgh.
NCT01187771 is a Phase 2 study of Obesity and Obstructive Sleep Apnea that has completed, run by University of Pittsburgh. The registered enrollment target is 53 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01187771, a Phase 2 study of Obesity and Obstructive Sleep Apnea, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 53 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the feasibility of conducting a comparative effectiveness study comparing a medical versus surgical approach to the initial management of obstructive sleep apnea (OSA) in the setting of obesity.
Primary Outcome
The Effective Apnea Hypopnea Index (AHI) is the actual frequency of apneas and hypopneas per hour that the patient is exposed to. It is calculated as the AHI while on CPAP times the proportion of sleep time that CPAP was used plus the AHI off CPAP times the proportion of sleep time that CPAP is not used.
Conditions Studied
Interventions
- PROCEDURE Continuous Positive Airway Pressure
- PROCEDURE Laparoscopic Gastric Banding
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
What the finished NCT01187771 record still lists
NCT01187771 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Continuous Positive Airway Pressure is the first listed.
NCT01187771 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01187771 about?
NCT01187771 is a clinical study titled "Apnea, Bariatric Surgery Versus Continuous Positive Airway Pressure (CPAP) Trial". The purpose of this study is to assess the feasibility of conducting a comparative effectiveness study comparing a medical versus surgical approach to the initial management of obstructive sleep apnea (OSA) in the setting of obesity.
What is the current status of trial NCT01187771?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2010-11. Estimated completion is 2014-12.
What conditions does trial NCT01187771 study?
This clinical trial studies the following conditions: Obesity, Obstructive Sleep Apnea.
What interventions are being tested in trial NCT01187771?
The interventions under investigation include: Continuous Positive Airway Pressure (PROCEDURE), Laparoscopic Gastric Banding (PROCEDURE).
Who is sponsoring clinical trial NCT01187771?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01187771 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01187771's enrollment target sits among peer trials
53 700th of 1053 higher than 349 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatment After Bariatric Surgery
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia